Skip to main content
SNWV logo

SANUWAVE Health Inc. (SNWV) Stock Price & Analysis

SANUWAVE Health Inc. (SNWV) — MoonshotScore 28/100 (Weak band), calculated Nov 18, 2026. Price $1.50 (-5.66%), as of the Nov 20, 2026 trading session; market cap $12.9M.

Educational signal · not a buy or sell recommendation · How to read this

$1.50 −$0.09 (-5.66%) Market Cap $12.9M

SANUWAVE Health Inc. · SNWV · NASDAQ

SANUWAVE Health, Inc. is a medical device company specializing in shock wave technology for regenerative medicine. Their flagship product, dermaPACE, targets diabetic foot ulcers using noninvasive acoustic shock waves.

Price as of Nov 20, 2026

Key Statistics

28 of 100

MoonshotScore v2 · SANUWAVE Health (SNWV)

Weak
Business Quality Elite (90)
Financial Safety Strained (21)
Valuation Cheap (80)
Growth Durability Growing (62)
Momentum Falling (15)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Elite quality, at a cheap price, but a fragile balance sheet. The score also carries a risk penalty for a bankruptcy-risk score in the distress zone and reported profit not backed by cash flow. Business Quality: Elite; Financial Safety: Strained; Valuation: Cheap; Growth Durability: Growing; Momentum: Falling.

  • quarterly revenue $9M (Q3 FY2026, quarter ended Sep 30, 2026)
  • EPS beat 4 of the last 8 reports
  • Altman Z -8.42 · Piotroski F 7

Holding back: balance-sheet strain, weak price trend

Helping: business quality, an attractive price

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for SNWV (58 recorded, newest six shown)
RecordedScoreBand
29Weak
29Weak
29Weak
28Weak
28Weak
28Weak

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$1.50
Change on the day-5.66%
52-week range$1.50 – $35.29
Market capitalisation$12.9M—
Price / earnings (trailing)5.67
Shares traded on the day57.7K

Price & events

Other perspectives

Council score for SANUWAVE Health (SNWV): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Strong
Financial Safety Weak
Valuation Strong
Growth Durability Moderate
Momentum Negative

Legends Council

3 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Neutral read
Moon AI lens (model) Favorable read

Read on: Nov 13, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Fairly Valued
Profit Margin Strong
Revenue Growth Strong
Debt/Equity Negative
Gross Margin Strong

Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 21, 2026, except a card that shows its own read date.

1 · What is it?

What is SANUWAVE Health (SNWV), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. SANUWAVE Health Inc. (SNWV) is listed on NASDAQ. It employs 55 people and is led by Morgan C. Frank. In Q3 FY2026 it reported revenue of $9M and net income of -$1M. The market values it at $12.9M.

2 · Latest results

What do the latest results show for SANUWAVE Health (SNWV)?

Short answer · as of

The most recent reported quarter, Q3 FY2026, carried revenue of $9M. Against analyst estimates the company has EPS beat 4 of the last 8 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q3 FY2026$9M-$1M-$0.16 (diluted)
Q2 FY2026$10M-$682,000-$0.08 (diluted)
Q1 FY2026$10M-$1M-$0.17 (diluted)
Q4 FY2025$13M$6M$0.02 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for SANUWAVE Health (SNWV)?

Short answer · as of

The MoonshotScore pillars rate business quality, an attractive price as strengths. What is holding it back is balance-sheet strain, weak price trend. The distress and quality screens read Altman Z -8.42 · Piotroski F 7. Trailing ratios: ROE 113.1% · ROA 7.9% · current ratio 1.18 · earnings yield 16.4% · free-cash-flow yield 16.8%.

5 · Peer comparison

How does SANUWAVE Health compare with its peers?

Short answer

SANUWAVE Health's score ranks 13th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Viemed Healthcare, Inc. (VMD) Same industry, near in market value$8.52 Nov 20, 2026$323M88 5-pillar Nov 18, 2026
Electromed, Inc. (ELMD) Same industry, near in market value$22.98 Nov 20, 2026$188M87 5-pillar Nov 18, 2026
BrainsWay Ltd. (BWAY) Same industry, near in market value$8.73 Nov 19, 2026$351M87 5-pillar Nov 18, 2026
Anika Therapeutics, Inc. (ANIK) Same industry, near in market value$13.23 Nov 20, 2026$177M71 5-pillar Nov 18, 2026
LENSAR, Inc. (LNSR) Same industry, near in market value$4.64 Nov 19, 2026$57.1M44 5-pillar Nov 18, 2026
Solana Company (HSDT) Same industry, near in market value$1.49 Nov 20, 2026$93.7M43 5-pillar Nov 18, 2026
Owlet, Inc. (OWLT) Same industry, near in market value$3.23 Nov 19, 2026$96.5M41 5-pillar Nov 18, 2026
Hyperion DeFi, Inc. (HYPD) Same industry, near in market value$2.08 Nov 20, 2026$31.7M39 5-pillar Nov 18, 2026
Inogen, Inc. (INGN) Same industry, near in market value$5.30 Nov 20, 2026$138M37 5-pillar Nov 18, 2026
Orthofix Medical Inc. (OFIX) Same industry, near in market value$6.07 Nov 20, 2026$247M36 5-pillar Nov 18, 2026
908 Devices Inc. (MASS) Same industry, near in market value$8.67 Nov 20, 2026$361M35 5-pillar Nov 18, 2026
Apyx Medical Corporation (APYX) Same industry, near in market value$2.39 Nov 19, 2026$101M33 5-pillar Nov 18, 2026
SANUWAVE Health (SNWV) — this page$1.50$12.9M28

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Insider activity

Form 4 records via FMP · Most recent available transactions

Transactions
12
Identified insiders
2
Purchases
0
Sales
12
Other transactions
0

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held SNWV in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported SNWV in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about SANUWAVE Health (SNWV)?

Read these with our analysis →

Investor Questions: SNWV Stock

These answers are editorial: 1 of these 9 answers is drawn from the SNWV research dossier (written May 10, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for SNWV?

SNWV carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. SANUWAVE Health, Inc. is a medical device company specializing in shock wave technology for regenerative medicine.

Is SNWV a good stock to buy?

Stock Expert AI does not rate SNWV buy, sell or hold. SANUWAVE Health Inc. carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the SNWV stock price today?

The last price recorded for SANUWAVE Health Inc. (SNWV), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What do analysts say about SNWV stock?

Analyst coverage of SANUWAVE Health, Inc. is limited, but existing reports suggest a focus on the company's growth potential within the regenerative medicine sector. Key valuation metrics include market capitalization, P/E ratio, and gross margin.

What are the key factors to evaluate for SNWV?

SANUWAVE Health Inc. (SNWV) holds a MoonshotScore in the low range. To weigh it, start with the trailing P/E under Price & valuation on this page. Analysts target $54.00 (+3500%). Collaborating with hospitals, clinics, and wound care centers can increase access to dermaPACE and UltraMIST for patients. Not financial advice.

How frequently does SNWV data refresh on this page?

SNWV's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven SNWV's recent stock price performance?

SANUWAVE Health Inc. (SNWV) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary shock wave technology. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider SNWV overvalued or undervalued right now?

The trailing P/E of SANUWAVE Health Inc. (SNWV) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of SNWV?

Fractional-share availability for SANUWAVE Health Inc. (SNWV) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 17 figures on this page — 9 from Financial Modeling Prep (FMP), 7 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.